The emergence of common imatinib represents a significant opportunity for patients battling chronic myeloid leukemia and other conditions. Original brand-name imatinib, branded as Gleevec, carries a high price cost, https://generic-imatinib393671.itbloghub.com/853287/generic-imatinib-a-budget-friendly-option